Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06068439
PHASE2/PHASE3

Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

View on ClinicalTrials.gov

Summary

This is a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of low-dose aspirin (50 mg/day) in renal and cardiac function protection in people with diabetic nephropathy.

Official title: A Phase III Multi-center Randomized Placebo-controlled Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

355

Start Date

2024-01-01

Completion Date

2027-06-30

Last Updated

2023-10-05

Healthy Volunteers

No

Interventions

DRUG

Acetylsalicylic Acid

aspirin 50 mg/d to be taken after dinner (in nonfasting conditions)

DRUG

Placebo

Placebo 50 mg/d to be taken after dinner (in nonfasting conditions)